Search

everythinglearnresearchcommunity

for

Search:↓

LMWP-PDGFA shows promise for improving hair health and treating hair loss with fewer side effects.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Finasteride-loaded microemulsions can effectively enhance skin delivery for treating hair loss.

Finasteride blocks progesterone production in specific tumor cells, potentially causing side effects.

Ebastine may promote hair regrowth by increasing cell growth through the ERK pathway.

Topical tacrolimus reduces certain growth factors in hair follicles.

A new compound may treat benign prostatic hyperplasia better than finasteride.

The PRP-like cosmetic with biomimetic peptides is potentially effective and safe for treating alopecia areata.

A new method using hyaluronic acid liposomes improves Minoxidil's effectiveness and safety for hair growth treatment.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

Salvianolic acid B promotes hair growth better than minoxidil.

Pregnancy increases certain GABA_A receptors in rat brains, influenced by steroid levels.

Prophylactic pilocarpine may not prevent angle closure in the other eye.

Wnt3a activates certain genes in hair follicle cells, including a newly discovered one, EP2, which may affect hair growth.

The combination of minoxidil and betamethasone is more effective for hair regrowth than minoxidil alone.

New anti-acne medications are being tested to offer alternatives to current treatments.

Blocking certain brain processes reduces mating behavior in female rats.

New treatments for hair loss focus on targeting specific causes to improve effectiveness and safety.

The mineralocorticoid receptor temporarily affects mouse skin development, but the glucocorticoid receptor has a more lasting impact.

Finasteride blocks progesterone's effect on brain activity linked to epilepsy.

Bicalutamide may reduce hair shedding in women but needs longer trials to confirm its effectiveness.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Laminin-511 is involved in psoriasis development and can be regulated by cannabinoid receptor type 1.

Progesterone protects brain cells, but Provera does not.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

Topical corticosteroid foams are effective, safe, and easy to use for treating various skin conditions.

Neurosteroids can influence behavior by modulating brain inhibition, with potential for treating psychiatric disorders.

Lower MC2R expression may contribute to alopecia areata.